ARTICLE | Company News
Isis other research news
August 30, 2004 7:00 AM UTC
Researchers published in Cancer Cell that patients with PTEN-negative breast cancers had poorer responses to Herceptin trastuzumab treatment than patients with PTEN-positive tumors (p<0.01). PI3K in...